Fingerprint
Dive into the research topics of 'Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically